APT Medical Inc.
688617
Rang in Aktien
#3232
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
Aktienkurs
$38.62
Marktkapitalisierung
$5.47B
Veränderung (1 Tag)
0.19%
Veränderung (1 Jahr)
-17.07%
Land
CN
Handel APT Medical Inc. (688617)
Kategorie
Healthcare
Gewinn für APT Medical Inc. (688617)
Gewinn im Jun 2026 TTM: $158.75M
Laut den aktuellen Finanzberichten von APT Medical Inc. betragen die aktuellen Gewinne des Unternehmens $158.75M. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $102.20M, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $84.25M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von APT Medical Inc. von 2017 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $158.75M | 18.63% |
| 2025 | $133.82M | 30.94% |
| 2024 | $102.20M | 21.31% |
| 2023 | $84.25M | 47.08% |
| 2022 | $57.28M | 64.33% |
| 2021 | $34.86M | 87.86% |
| 2020 | $18.55M | 41.43% |
| 2019 | $13.12M | 288.78% |
| 2018 | $3.37M | -29.16% |
| 2017 | $4.76M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $6.56B | 4,033.47% |
US
|
|
| $6.60B | 4,059.29% |
IE
|
|
| $5.15B | 3,142.78% |
US
|
|
| $3.86B | 2,332.08% |
US
|
|
| $3.25B | 1,947.21% |
DE
|
